Anticancer drugs tamoxifen and 4hydroxytamoxifen as effectors of phosphatidylethanolamine lipid polymorphism.
Saved in:
| Title: | Anticancer drugs tamoxifen and 4hydroxytamoxifen as effectors of phosphatidylethanolamine lipid polymorphism. |
|---|---|
| Authors: | Ortiz J; Departamento de Bioquímica y Biología Molecular-A, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, E-30100 Murcia, Spain., Teruel JA; Departamento de Bioquímica y Biología Molecular-A, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, E-30100 Murcia, Spain., Aranda FJ; Departamento de Bioquímica y Biología Molecular-A, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, E-30100 Murcia, Spain., Ortiz A; Departamento de Bioquímica y Biología Molecular-A, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, E-30100 Murcia, Spain. Electronic address: ortizbq@um.es. |
| Source: | Chemistry and physics of lipids [Chem Phys Lipids] 2022 Oct; Vol. 248, pp. 105239. Date of Electronic Publication: 2022 Sep 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 0067206 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2941 (Electronic) Linking ISSN: 00093084 NLM ISO Abbreviation: Chem Phys Lipids Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2941 |
|---|---|
| DOI: | 10.1016/j.chemphyslip.2022.105239 |
